publication venue for
- Evaluating Rates of Recurrent Ischemic Stroke Among Young Adults With Embolic Stroke of Undetermined Source. 79:450-450. 2022
- Left Ventricular Dysfunction Among Patients With Embolic Stroke of Undetermined Source and the Effect of Rivaroxaban vs Aspirin. 78:1454-1454. 2021
-
Use and Safety of Immunotherapeutic Management of N-Methyl-
d -Aspartate Receptor Antibody Encephalitis. 78:1333-1333. 2021 - Microbleeds and the Effect of Anticoagulation in Patients With Embolic Stroke of Undetermined Source. 78:11-11. 2021
- A Pooled Analysis of Diffusion-Weighted Imaging Lesions in Patients With Acute Intracerebral Hemorrhage. 77:1390-1390. 2020
- Characteristics of Recurrent Ischemic Stroke After Embolic Stroke of Undetermined Source. 77:1233-1233. 2020
- Association Between Low-Dose Rivaroxaban With or Without Aspirin and Ischemic Stroke Subtypes. 77:43-43. 2020
- Developmental Trajectories of Infants With Multiplex Family Risk for Autism. 77:73-73. 2020
- Left Atrial Enlargement Could Be Detected on Extended Computed Tomography Angiography Within Initial Stroke Assessment—Reply. 77:134-134. 2020
- Recurrent Stroke With Rivaroxaban Compared With Aspirin According to Predictors of Atrial Fibrillation. 76:764-764. 2019
- Clinical, Radiologic, and Prognostic Features of Myelitis Associated With Myelin Oligodendrocyte Glycoprotein Autoantibody. 76:301-301. 2019
- Cerebral Microbleeds and the Effect of Intensive Blood Pressure Reduction on Hematoma Expansion and Functional Outcomes. 75:850-850. 2018
- Cognitive Decline in a Colombian Kindred With Autosomal Dominant Alzheimer Disease. 73:431-431. 2016
- Validation of Clinicoradiological Criteria for the Diagnosis of Cerebral Amyloid Angiopathy–Related Inflammation. 73:197-197. 2016
- Rarity of the Alzheimer Disease–ProtectiveAPPA673T Variant in the United States. 72:209-209. 2015
- Effects of Multiple Genetic Loci on Age at Onset in Late-Onset Alzheimer Disease. 71:1394-1394. 2014
- Inosine to Increase Serum and Cerebrospinal Fluid Urate in Parkinson Disease. 71:141-141. 2014
- Direct-Acting Oral Anticoagulants. 70:1483-1484. 2013
- Postvaccination Miller Fisher Syndrome. 68:1327-1327. 2011
- Plasticity, Hippocampal Place Cells, and Cognitive Maps. 58:874-874. 2001
- Duchenne Muscular Dystrophy Manifesting Carriers. 47:951-951. 1990
- Polymyositis in Chronic Graft vs Host Disease. 39:188-188. 1982